Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vosevi
Vosevi
FDA issues safety warning for newer hepatitis C drugs following patient deaths
Biopharma Dive
Wed, 08/28/19 - 11:02 pm
FDA
hepatitis C
FAERS
AbbVie
Mavyret
Merck
Zepatier
Gilead Sciences
Vosevi
Gilead Has Another Ace Up Its Sleeve
Seeking Alpha
Fri, 07/21/17 - 10:05 am
Gilead Sciences
hepatitis C
Vosevi
FDA's Flashing Green Light Boosts Novel Drug Approvals
Seeking Alpha
Thu, 07/20/17 - 06:03 pm
FDA
drug approvals
Gilead Sciences
Puma Biotechnology
Vosevi
Nerlynx
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
Investors Business Daily
Wed, 07/19/17 - 07:55 pm
AbbVie
Gilead Sciences
hepatitis C
Vosevi
Harvoni
Sovaldi
Epclusa
Viekira Pak
FDA OKs a new triple hep C drug from Gilead, keeping its grip on a shrinking market
Endpoints
Tue, 07/18/17 - 10:55 pm
Gilead Sciences
FDA
hepatitis C
Vosevi
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Sat, 06/24/17 - 09:11 am
Europe
EMA
hepatitis C
multiple sclerosis
breast cancer
renal cell carcinoma
AbbVie
Maviret
Gilead Sciences
Vosevi
Biogen
Amgen
Samsung Bioepis
biosimilars
Humira
Novartis
Kisqali
EUSA
Fotivda